These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 26142912

  • 1. Three-month treatment with triptorelin, letrozole and ulipristal acetate before hysteroscopic resection of uterine myomas: prospective comparative pilot study.
    Bizzarri N, Ghirardi V, Remorgida V, Venturini PL, Ferrero S.
    Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():22-6. PubMed ID: 26142912
    [Abstract] [Full Text] [Related]

  • 2. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status.
    Parsanezhad ME, Azmoon M, Alborzi S, Rajaeefard A, Zarei A, Kazerooni T, Frank V, Schmidt EH.
    Fertil Steril; 2010 Jan; 93(1):192-8. PubMed ID: 19135657
    [Abstract] [Full Text] [Related]

  • 3. GnRH analogue treatment before hysteroscopic resection of submucous myomas: a prospective, randomized, multicenter study.
    Muzii L, Boni T, Bellati F, Marana R, Ruggiero A, Zullo MA, Angioli R, Panici PB.
    Fertil Steril; 2010 Sep; 94(4):1496-1499. PubMed ID: 19541299
    [Abstract] [Full Text] [Related]

  • 4. Preoperative treatment with letrozole in patients undergoing laparoscopic myomectomy of large uterine myomas: a prospective non-randomized study.
    Leone Roberti Maggiore U, Scala C, Venturini PL, Ferrero S.
    Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():157-62. PubMed ID: 25150954
    [Abstract] [Full Text] [Related]

  • 5. Preoperative Treatment with Ulipristal Acetate before Outpatient Hysteroscopic Myomectomy.
    Ferrero S, Scala C, Vellone VG, Paudice M, Vitale SG, Cianci A, Barra F.
    Gynecol Obstet Invest; 2020 Oct; 85(2):178-183. PubMed ID: 31940645
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Transrectal ultrasound-guided hysteroscopic myomectomy of submucosal myomas with a varying degree of myometrial penetration.
    Ludwin A, Ludwin I, Pityński K, Basta P, Basta A, Banas T, Jach R, Wiecheć M, Grabowska R, Stangel-Wójcikiewicz K, Milewicz T, Nocuń A.
    J Minim Invasive Gynecol; 2013 Oct; 20(5):672-85. PubMed ID: 23850363
    [Abstract] [Full Text] [Related]

  • 8. A Multicenter Study Evaluating the Effect of Ulipristal Acetate during Myomectomy.
    Murji A, Wais M, Lee S, Pham A, Tai M, Liu G.
    J Minim Invasive Gynecol; 2018 Oct; 25(3):514-521. PubMed ID: 29079463
    [Abstract] [Full Text] [Related]

  • 9. A new system to classify submucous myomas: a Brazilian multicenter study.
    Lasmar RB, Lasmar BP, Celeste RK, da Rosa DB, Depes Dde B, Lopes RG.
    J Minim Invasive Gynecol; 2012 Oct; 19(5):575-80. PubMed ID: 22819007
    [Abstract] [Full Text] [Related]

  • 10. Short-term and long-term results of resectoscopic myomectomy with and without pretreatment with GnRH analogs in premenopausal women.
    Campo S, Campo V, Gambadauro P.
    Acta Obstet Gynecol Scand; 2005 Aug; 84(8):756-60. PubMed ID: 16026401
    [Abstract] [Full Text] [Related]

  • 11. [Operative hysteroscopy for myoma removal: Morcellation versus bipolar loop resection].
    Hamidouche A, Vincienne M, Thubert T, Trichot C, Demoulin G, Nazac A, Fernandez H, Rivain AL, Deffieux X.
    J Gynecol Obstet Biol Reprod (Paris); 2015 Sep; 44(7):658-64. PubMed ID: 25287109
    [Abstract] [Full Text] [Related]

  • 12. Three-month treatment with ulipristal acetate prior to laparoscopic myomectomy of large uterine myomas: a retrospective study.
    Ferrero S, Alessandri F, Vellone VG, Venturini PL, Leone Roberti Maggiore U.
    Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():43-7. PubMed ID: 27566221
    [Abstract] [Full Text] [Related]

  • 13. Hysteroscopic management of large symptomatic submucous uterine myomas.
    Camanni M, Bonino L, Delpiano EM, Ferrero B, Migliaretti G, Deltetto F.
    J Minim Invasive Gynecol; 2010 Oct; 17(1):59-65. PubMed ID: 20129334
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hysteroscopic morcellation versus bipolar resection for removal of type 0 and 1 submucous myomas: A randomized trial.
    van Wessel S, van Vliet HAAM, Schoot BC, Weyers S, Hamerlynck TWO.
    Eur J Obstet Gynecol Reprod Biol; 2021 Apr; 259():32-37. PubMed ID: 33571839
    [Abstract] [Full Text] [Related]

  • 17. Laparoscopic Myomectomy for a Plethora of Submucous Myomas.
    Paul PG, Paul G, Radhika KT, Bulusu S, Shintre H.
    J Minim Invasive Gynecol; 2017 Apr; 24(6):893-894. PubMed ID: 28232038
    [Abstract] [Full Text] [Related]

  • 18. Monopolar versus bipolar device: safety, feasibility, limits and perioperative complications in performing hysteroscopic myomectomy.
    Litta P, Leggieri C, Conte L, Dalla Toffola A, Multinu F, Angioni S.
    Clin Exp Obstet Gynecol; 2014 Apr; 41(3):335-8. PubMed ID: 24992788
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Submucous myomas and their implications in the pregnancy rates of patients with otherwise unexplained primary infertility undergoing hysteroscopic myomectomy: a randomized matched control study.
    Shokeir T, El-Shafei M, Yousef H, Allam AF, Sadek E.
    Fertil Steril; 2010 Jul; 94(2):724-9. PubMed ID: 19406399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.